Endogena
San Francisco
About Endogena
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders. The company implements innovation in the field of regenerative medicine. Their science combines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $29.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: endogena.com
- Phone: 415-433-2262
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/endogena-96457 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.